HAYA Therapeutics SA
Treating heart failure through innovative RNA-therapies
HAYA Therapeutics is dedicated to treating heart failure through the discovery and development of innovative first-in-class RNA-based therapeutics, with a specific focus on long noncoding RNAs.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
01.09.2025
New Startup Innovation Projects set to advance their technologies (startupticker.ch)
25.06.2025
2025 WEF Technology Pioneers highlight two Swiss Startups (startupticker.ch)
03.06.2025
Un jubilé synonyme de renaissance (startupticker.ch)
08.05.2025
HAYA Therapeutics banks $65 million Series A funding (startupticker.ch)
08.05.2025
HAYA Therapeutics secures USD 65M to advance RNA-guided therapies for chronic and age-related diseases (venturelab.swiss)
Last Tweets
No milestones
No Jobs
Videos
Startup Champions Seed Night 2018
TOP 100 Swiss Startup Award
The TOP 100 Swiss Startup Ranking features the 100 most promising startups that are not older than five years and are selected by a jury of early-stage investors.
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Venture Leaders Life Sciences
The venture leaders - the members of the Swiss national startup team- have a clear-cut goal. They envision themselves as global players and want to take the first step to their global expansion. The ten-day business development program is specifically structured to help them achieve this goal.
HAYA Therapeutics SA
Treating heart failure through innovative RNA-therapies
Website:
www.hayatx.com
Headquarter:
Epalinges
Foundation Date:
July 2019
Technology:
- Biotech
Sectors:
- Biotech
- Cardiovascular
- Drug discovery
- Organ and Tissues
Support received
